These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15001252)

  • 1. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors.
    Wada H; Takai Y; Nemoto K; Yamada S
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1114-20. PubMed ID: 15001252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer.
    Kim H; Ahn YC; Park HC; Lim DH; Nam H
    J Thorac Oncol; 2010 Apr; 5(4):526-32. PubMed ID: 20104193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.
    Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].
    Xi M; Liu MZ; Deng XW; Liu H; Huang XY; Zhang L; Li QQ; Hu YH; Cai L; Cui NJ
    Ai Zheng; 2007 Jan; 26(1):1-8. PubMed ID: 17222359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiotherapy of targets in the lung and liver.
    Wulf J; Hädinger U; Oppitz U; Thiele W; Ness-Dourdoumas R; Flentje M
    Strahlenther Onkol; 2001 Dec; 177(12):645-55. PubMed ID: 11789403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
    Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
    Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH; Chen LH
    Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Kim YS; Yoon SM; Choi EK; Yi BY; Kim JH; Ahn SD; Lee SW; Shin SS; Lee JS; Suh C; Kim SW; Kim DS; Kim WS; Park HJ; Park CI
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):76-81. PubMed ID: 15850905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
    Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame.
    Nagata Y; Negoro Y; Aoki T; Mizowaki T; Takayama K; Kokubo M; Araki N; Mitsumori M; Sasai K; Shibamoto Y; Koga S; Yano S; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1041-6. PubMed ID: 11958900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
    Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
    Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
    Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
    Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
    Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD
    Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.